Drugs for preventing lung cancer in healthy people (Q24198265)

1

0 references

José-Ramón Rueda

2

0 references

Gilda Corsini-Muñoz

3

0 references

Carolina Fonseca-Cortés

4

0 references

Magali Caraballoso

Cochrane Database of Systematic Reviews

5

0 references

publication date

17 October 2012

0 references

published in

0 references

cites work

Alpha-Tocopherol and beta-carotene supplements and lung cancer incidence in the alpha-tocopherol, beta-carotene cancer prevention study: effects of base-line characteristics and study compliance

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002141.PUB2

The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002141.PUB2

Incidence of cancer and mortality following alpha-tocopherol and beta-carotene supplementation: a postintervention follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002141.PUB2

Design of Physicians' Health Study II--a randomized trial of beta-carotene, vitamins E and C, and multivitamins, in prevention of cancer, cardiovascular disease, and eye disease, and review of results of completed trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002141.PUB2

Vitamins E and C in the prevention of prostate and total cancer in men: the Physicians' Health Study II randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002141.PUB2

Effects of beta-carotene supplementation on cancer incidence by baseline characteristics in the Physicians' Health Study (United States).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002141.PUB2

Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002141.PUB2

A randomized trial of aspirin and beta-carotene among U.S. physicians

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002141.PUB2

Final report on the aspirin component of the ongoing Physicians' Health Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002141.PUB2

The SU.VI.MAX Study: a randomized, placebo-controlled trial of the health effects of antioxidant vitamins and minerals

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002141.PUB2

Incidence of cancers, ischemic cardiovascular diseases and mortality during 5-year follow-up after stopping antioxidant vitamins and minerals supplements: a postintervention follow-up in the SU.VI.MAX Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002141.PUB2

A primary prevention trial using nutritional doses of antioxidant vitamins and minerals in cardiovascular diseases and cancers in a general population: the SU.VI.MAX study--design, methods, and participant characteristics. SUpplementation en VItamin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002141.PUB2

Lung Cancer Chemoprevention: A Randomized, Double-Blind Trial in Linxian, China

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002141.PUB2

Total and cancer mortality after supplementation with vitamins and minerals: follow-up of the Linxian General Population Nutrition Intervention Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002141.PUB2

Aspirin prevents stroke but not MI in women; vitamin E has no effect on CV disease or cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002141.PUB2

Vitamin E in the primary prevention of cardiovascular disease and cancer: the Women's Health Study: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002141.PUB2

Vitamins C and E and beta carotene supplementation and cancer risk: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002141.PUB2

Effect of combined folic acid, vitamin B6, and vitamin B12 on cancer risk in women: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002141.PUB2

Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002141.PUB2

The protective effect of beta-carotene and retinol on ventilatory function in an asbestos-exposed cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002141.PUB2

The Beta-Carotene and Retinol Efficacy Trial: incidence of lung cancer and cardiovascular disease mortality during 6-year follow-up after stopping beta-carotene and retinol supplements

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002141.PUB2

Risk factors for lung cancer and for intervention effects in CARET, the Beta-Carotene and Retinol Efficacy Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002141.PUB2

Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002141.PUB2

Statistical design and monitoring of the carotene and retinol efficacy trial (CARET)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002141.PUB2

The effect of the synthetic retinoid etretinate on sputum cytology: results from a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002141.PUB2

Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002141.PUB2

Vitamin A and cancer prevention II: comparison of the effects of retinol and beta-carotene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002141.PUB2

Vitamin A and cancer prevention I: observations in workers previously exposed to asbestos at Wittenoom, Western Australia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002141.PUB2

The EUROSCAN Study. EUROSCAN Steering Committee

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002141.PUB2

Randomized placebo-controlled trial of isotretinoin in chemoprevention of bronchial squamous metaplasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002141.PUB2

Randomized phase III intergroup trial of isotretinoin to prevent second primary tumors in stage I non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002141.PUB2

Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002141.PUB2

Adjuvant treatment of stage I lung cancer with high-dose vitamin A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002141.PUB2

Randomized trial of fenretinide to prevent second breast malignancy in women with early breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002141.PUB2

Non-organ-specific preventive effect of long-term administration of Korean red ginseng extract on incidence of human cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002141.PUB2

Silica exposure, smoking, silicosis and lung cancer--complex interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002141.PUB2

Serum retinol, beta-carotene, vitamin E, and selenium as related to subsequent cancer of specific sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002141.PUB2

Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002141.PUB2

Beta-carotene supplementation and cancer risk: a systematic review and metaanalysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002141.PUB2

Retinol, vitamins, and cancer prevention: 25 years of learning and relearning

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002141.PUB2

Cancer chemoprevention and therapy by monoterpenes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002141.PUB2

21 January 2018

Cancer chemoprevention

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002141.PUB2

Dietary intake of selected B vitamins in relation to risk of major cancers in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002141.PUB2

Effects of antioxidant supplements on cancer prevention: meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002141.PUB2

Can dietary beta-carotene materially reduce human cancer rates?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002141.PUB2

The nutritional prevention of cancer: 400 mcg per day selenium treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002141.PUB2

Biology and chemoprevention of lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002141.PUB2

Chemoprevention of cancer: a controversial and instructive story

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002141.PUB2

Lung cancer risk and consumption of vegetables and fruit: an evaluation based on a systematic review of epidemiological evidence from Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002141.PUB2

Nutritional approach to cancer prevention with emphasis on vitamins, antioxidants, and carotenoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002141.PUB2

Retinoids in chemoprevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002141.PUB2

Drugs for preventing lung cancer in healthy people

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002141.PUB2

Lung cancer chemoprevention with retinol palmitate. Preliminary data from a randomized trial on stage Ia non small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002141.PUB2

Promoter Methylation and Silencing of the Retinoic Acid Receptor- Gene in Lung Carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002141.PUB2

Designing the Selenium and Vitamin E Cancer Prevention Trial (SELECT)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002141.PUB2

The CARET asbestos-exposed cohort: Baseline characteristics and comparison to other asbestos-exposed cohorts

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002141.PUB2

7 January 2021

Prevention of second primary tumours with etretinate in squamous cell carcinoma of the oral cavity and oropharynx. Results of a multicentric double-blind randomised study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002141.PUB2

7 January 2021

Linxian nutrition intervention trials. Design, methods, participant characteristics, and compliance

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002141.PUB2

7 January 2021

A secondary prevention trial of antioxidant vitamins and cardiovascular disease in women. Rationale, design, and methods. The WACS Research Group

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002141.PUB2

7 January 2021

The alpha-tocopherol, beta-carotene lung cancer prevention study: design, methods, participant characteristics, and compliance. The ATBC Cancer Prevention Study Group

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002141.PUB2

7 January 2021

"The SU.VI.MAX Study": a primary prevention trial using nutritional doses of antioxidant vitamins and minerals in cardiovascular diseases and cancers. SUpplementation on VItamines et Minéraux AntioXydants

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002141.PUB2

7 January 2021

Inhibition of oxidative DNA damage, 8-OHdG, and carbonyl contents in smokers treated with antioxidants (vitamin E, vitamin C, beta-carotene and red ginseng)

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002141.PUB2

7 January 2021

Preliminary report: Findings from the aspirin component of the ongoing Physicians' Health Study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002141.PUB2

7 January 2021

Prevention of second primary tumors with isotretinoin in squamous-cell carcinoma of the head and neck

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002141.PUB2

7 January 2021

Lung cancer and vitamin supplementation

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002141.PUB2

7 January 2021

Baseline Characteristics of Participants in the Women's Health Study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002141.PUB2

7 January 2021

The Linxian trials: mortality rates by vitamin-mineral intervention group

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002141.PUB2

7 January 2021

Beta-Carotene, vitamin A, and lung cancer chemoprevention: results of an intermediate endpoint study.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002141.PUB2

7 January 2021

Clinical trials of vitamin and mineral supplements for cancer prevention

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002141.PUB2

7 January 2021

Carotenoids and the risk of developing lung cancer: a systematic review

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002141.PUB2

7 January 2021

Etretinate blood levels in monitoring of compliance and contamination in a chemoprevention trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002141.PUB2

7 January 2021

Nutrition intervention trials in Linxian, China: supplementation with specific vitamin/mineral combinations, cancer incidence, and disease-specific mortality in the general population

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002141.PUB2

7 January 2021

Beta-carotene supplementation and incidence of cancer and cardiovascular disease: the Women's Health Study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002141.PUB2

7 January 2021

EUROSCAN, a randomized trial of vitamin A and N-acetylcysteine in patients with head and neck cancer or lung cancer. For the EUropean Organization for Research and Treatment of Cancer Head and Neck and Lung Cancer Cooperative Groups

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002141.PUB2

7 January 2021

Placebo-controlled trial of 13-cis-retinoic acid activity on retinoic acid receptor-beta expression in a population at high risk: implications for chemoprevention of lung cancer

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002141.PUB2

7 January 2021

Chemoprevention of lung cancer

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD002141.PUB2

7 January 2021